Search Results | Showing 1 - 10 of 30 results for "Pfizer" |
| | | ... Nevertheless, takeovers were the major driver of the increase in corporate net borrowing. Deals in the healthcare sector, including Pfizer's purchase of Seagen, accounted for nearly one third of the rise. However, across all sectors, Janus Henderson ... |
| | | | ... Budget by way of a new focus on sovereign manufacturing capability. New federal funding will see mRNA vaccines - like the Pfizer and Moderna vaccines - manufactured in Victoria. Environmental spending still contentious While the LNP government has been ... |
| | | | ... further efforts to match global standards. Examples of global firms partnering with Chinese businesses include AstraZeneca, Pfizer and Novartis, while Chinese firms such as BeiGene and Legend Biotech have also found multinational partners. "Authorities ... |
| | | | ... the rollout, with more than 500,000 aged and disability care residents and staff" for a total of 678,000. About 60,000 Pfizer/BioNTech COVID-19 vaccine doses are expected to be administered to priority groups by the end of the first week." Phase 1B will ... |
| | | | ... the coronavirus vaccine but at this point supply remains limited. According to Factset: "Washington Post reported that Pfizer told the Trump administration it cannot provide substantial additional doses of its vaccine until late June or July... FT also ... |
| | | | ... to remain stable at standard refrigerator temperatures of 2-8 degrees centigrade for up to 30 days. This is better than Pfizer and BioNTech's candidate which reportedly is 90% effective and needs to be stored at around minus 70 degrees centigrade. ... |
| | | | ... days. This comes in the wake of some of the logistics/distribution concerns (WSJ) surrounding the vaccine candidate from Pfizer (PFE-US ) and BioNTech (BNTX-US ). While the recently announced efficacy rate was also over 90%, helping to unleash a bullish ... |
| | | | ... US$41.36 per barrel; Brent oil to US$43.61 - following reports of encouraging COVID-19 vaccine test results developed by Pfizer and BioNTech. The easing of US presidential election uncertainty, topped by Joe Biden trumping Donald Trump has also helped ... |
| | | | ... that soon, the coronavirus pandemic too, shall pass following encouraging test results for a COVID-19 vaccine developed by Pfizer and BioNTech. |
| | | | It's beginning to look a lot like Christmas. Encouraging test results for a COVID-19 vaccine developed by Pfizer and BioNTech sent world equity markets from New York to Rio and ol' London town on the up and up and up. Pfizer and BioNTech are ... |
|